Immunology &
Transplant Medicines
Euro Biom supplies immunology and transplant medicines to specialist hospital centres and international healthcare buyers. Our portfolio includes immunosuppressants, biologics and transplant rejection prophylaxis medicines, sourced from UK and EU-licensed manufacturers.
Search Our Immunology & Transplant Range
All products sourced from UK and EU licensed manufacturers. Contact us to enquire about any product.
Showing all 41 products
No products found. Contact us, we can likely source it.
Immunology & Transplant Medicine Supply for Hospitals & International Buyers
Organ transplantation depends on the uninterrupted supply of immunosuppressant medicines from the moment of transplant surgery and throughout the patient's lifetime. Any gap in supply can trigger acute rejection, lead to graft loss and require costly and high-risk re-transplantation or return to dialysis. The consequences of even a brief interruption to tacrolimus or ciclosporin therapy can be irreversible, which means transplant centres treat their immunosuppressant supply chains with the same clinical urgency as the surgical programme itself. Euro Biom works directly with transplant hospital procurement teams, specialist pharmacy departments and international distributors to ensure these medicines are available at all times, including in urgent and shortage scenarios.
Tacrolimus is the cornerstone immunosuppressant for kidney, liver, heart and lung transplantation. It is available in immediate-release capsules (Prograf and generics) and the modified-release formulation Advagraf, which offers once-daily dosing and improved adherence. A critical clinical consideration for international buyers is that tacrolimus products are not interchangeable without close therapeutic drug monitoring: the pharmacokinetic profiles of different brands and formulations differ, and switching requires clinical supervision. Many transplant centres therefore specify brand continuity rather than generic substitution. Euro Biom regularly supplies specific tacrolimus brands for GCC and African transplant programmes where the patient was stabilised on a UK-branded product and continuity is essential for safety.
Ciclosporin remains in use for renal, hepatic and cardiac transplant maintenance, and is also used in dermatology, rheumatology and ophthalmology. Neoral (ciclosporin microemulsion) is the formulation most commonly specified in transplant protocols, and like tacrolimus it is not generically interchangeable without monitoring. We hold Neoral and can source ciclosporin eye drops (Ikervis, Restasis) for specialist ophthalmic indications. Azathioprine, an older antimetabolite still used in combination regimens and as a steroid-sparing agent in autoimmune conditions, is also available across standard strengths.
Mycophenolate mofetil (CellCept and generics) is used alongside calcineurin inhibitors in most transplant maintenance protocols to reduce rejection rates. Dosing in transplant patients is weight-based and adjusted by tolerability, and some protocols use enteric-coated mycophenolate sodium (Myfortic) in patients who experience gastrointestinal side effects with the mofetil form. Both formulations are available through our supply network. mTOR inhibitors sirolimus (rapamycin) and everolimus are used in calcineurin-inhibitor-sparing regimens and in selected cardiac and liver transplant protocols, and are regularly requested by international buyers where local market supply is unreliable.
Biologics for Autoimmune Disease and Specialist Immunoglobulin Supply
Biologic therapies have transformed the management of autoimmune conditions including rheumatoid arthritis, inflammatory bowel disease, psoriasis and vasculitis. TNF-alpha inhibitors such as adalimumab (Humira and biosimilars) and infliximab (Remicade and biosimilars) are among the most widely prescribed biologics globally. Rituximab is used in B-cell driven autoimmune conditions including lupus nephritis, ANCA vasculitis and pemphigus, as well as haematological malignancies. Tocilizumab, which targets the IL-6 receptor, is used in rheumatoid arthritis and cytokine release syndrome. For GCC and African hospital buyers, access to these biologics is often constrained by limited local registration, high cost, or dependence on a single distribution channel. Euro Biom can supply these agents under named patient and special import frameworks, with full regulatory documentation to support import clearance.
Intravenous immunoglobulin (IVIG) is a high-demand, supply-constrained product used across a wide range of indications: primary immunodeficiency, Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), immune thrombocytopenic purpura (ITP), Kawasaki disease and post-transplant immunodeficiency management. Products such as Privigen, Kiovig, Flebogamma and Gamunex are commonly requested. IVIG is a plasma-derived product subject to global supply pressures, and hospitals in regions without domestic plasma fractionation infrastructure, including most of the GCC and Africa, depend entirely on imported supply. Euro Biom sources IVIG from licensed UK and European wholesalers and can supply named brands with full batch traceability and cold-chain documentation.
Corticosteroids are foundational in both transplant and autoimmune protocols. High-dose intravenous methylprednisolone (Solu-Medrol) is used for acute rejection episodes and autoimmune flares. Oral prednisolone at various doses forms part of maintenance regimens in transplant, inflammatory bowel disease, vasculitis and connective tissue diseases. Hydrocortisone is used in adrenal crisis, severe allergic reactions and perioperative cover in steroid-dependent patients. These medicines are stocked across multiple strengths and presentations, with capability for urgent dispatch where patient safety requires it.
GCC transplant programmes have expanded significantly over the past decade, with kidney and liver transplantation now well-established in Saudi Arabia, the UAE, Kuwait and Qatar. These programmes typically use UK and European sourced medicines as their reference standard, and their procurement teams often look to UK licensed wholesalers as their primary supply partners. Euro Biom holds a MHRA Wholesale Dealer Authorisation and operates under GDP principles, which means our documentation, storage and cold-chain processes meet the standards required for import licensing in GCC health authority frameworks. Our named patient team has extensive experience managing the clinical, regulatory and logistical requirements of transplant medicine supply for international buyers.
Need a Specific Product?
Can't find what you're looking for? We specialise in sourcing hard-to-find immunosuppressant and transplant medicines through our licensed supply network.
Submit an Enquiry →